Clinical Trial Update: A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing nivolumab plus cabozantinib to sunitinib in patients with previously untreated advanced or metastatic renal cell carcinoma. The study re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sunitinib (sunitinib)
• cabozantinib (cabozantinib)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Renal Cell Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-04-26